Cargando…
Drug Repurposing for Tooth Regeneration: The Promising Premises
Drug repurposing which identifies new therapeutic use(s) for drugs currently in use is a brand-new avenue of research interest worldwide. It circumvents the high-end monetary and time investment usually associated with contemporary drug discoveries. In the field of dentistry, recent studies in drug...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687015/ https://www.ncbi.nlm.nih.gov/pubmed/35017906 http://dx.doi.org/10.4103/jpbs.jpbs_67_21 |
_version_ | 1784618129526095872 |
---|---|
author | Divya, TC Muddappa, Sapna Chandira Singh, Prabath Rajan, Rakesh R Remya, M Sreehari, Deepthy |
author_facet | Divya, TC Muddappa, Sapna Chandira Singh, Prabath Rajan, Rakesh R Remya, M Sreehari, Deepthy |
author_sort | Divya, TC |
collection | PubMed |
description | Drug repurposing which identifies new therapeutic use(s) for drugs currently in use is a brand-new avenue of research interest worldwide. It circumvents the high-end monetary and time investment usually associated with contemporary drug discoveries. In the field of dentistry, recent studies in drug repurposing focuses in attaining dentin repair or reduction of bone resorption associated with apical periodontitis. Metformin, an anti-diabetic drug has shown pro-osteogenic properties. Aspirin a known anti-inflammatory agent with anticoagulant action is found to modulate the differentiation of dental pulp cells. The significant role of glycogen synthase kinase-3 inhibitors in activating the Wnt/-beta cat signaling pathway of mesenchymal pulp stem cells may pave the way to the pharmacological treatment of dental caries in near future. It is to be noted here that further preclinical and clinical studies are warranted for the regular therapeutic use of these potential drugs in clinical dentistry. |
format | Online Article Text |
id | pubmed-8687015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-86870152022-01-10 Drug Repurposing for Tooth Regeneration: The Promising Premises Divya, TC Muddappa, Sapna Chandira Singh, Prabath Rajan, Rakesh R Remya, M Sreehari, Deepthy J Pharm Bioallied Sci Review Article Drug repurposing which identifies new therapeutic use(s) for drugs currently in use is a brand-new avenue of research interest worldwide. It circumvents the high-end monetary and time investment usually associated with contemporary drug discoveries. In the field of dentistry, recent studies in drug repurposing focuses in attaining dentin repair or reduction of bone resorption associated with apical periodontitis. Metformin, an anti-diabetic drug has shown pro-osteogenic properties. Aspirin a known anti-inflammatory agent with anticoagulant action is found to modulate the differentiation of dental pulp cells. The significant role of glycogen synthase kinase-3 inhibitors in activating the Wnt/-beta cat signaling pathway of mesenchymal pulp stem cells may pave the way to the pharmacological treatment of dental caries in near future. It is to be noted here that further preclinical and clinical studies are warranted for the regular therapeutic use of these potential drugs in clinical dentistry. Wolters Kluwer - Medknow 2021-11 2021-11-10 /pmc/articles/PMC8687015/ /pubmed/35017906 http://dx.doi.org/10.4103/jpbs.jpbs_67_21 Text en Copyright: © 2021 Journal of Pharmacy and Bioallied Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Divya, TC Muddappa, Sapna Chandira Singh, Prabath Rajan, Rakesh R Remya, M Sreehari, Deepthy Drug Repurposing for Tooth Regeneration: The Promising Premises |
title | Drug Repurposing for Tooth Regeneration: The Promising Premises |
title_full | Drug Repurposing for Tooth Regeneration: The Promising Premises |
title_fullStr | Drug Repurposing for Tooth Regeneration: The Promising Premises |
title_full_unstemmed | Drug Repurposing for Tooth Regeneration: The Promising Premises |
title_short | Drug Repurposing for Tooth Regeneration: The Promising Premises |
title_sort | drug repurposing for tooth regeneration: the promising premises |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687015/ https://www.ncbi.nlm.nih.gov/pubmed/35017906 http://dx.doi.org/10.4103/jpbs.jpbs_67_21 |
work_keys_str_mv | AT divyatc drugrepurposingfortoothregenerationthepromisingpremises AT muddappasapnachandira drugrepurposingfortoothregenerationthepromisingpremises AT singhprabath drugrepurposingfortoothregenerationthepromisingpremises AT rajanrakeshr drugrepurposingfortoothregenerationthepromisingpremises AT remyam drugrepurposingfortoothregenerationthepromisingpremises AT sreeharideepthy drugrepurposingfortoothregenerationthepromisingpremises |